echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > CDE Releases Guidelines for Clinical Trials of LituxiM-Injectable Biosimilar Drugs

    CDE Releases Guidelines for Clinical Trials of LituxiM-Injectable Biosimilar Drugs

    • Last Update: 2020-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Guide the clinical research and development of litoxiin repellent biosimilar drugs in China! To guide the clinical development of biosimilars of rituximab injections in China, and to provide referencetechnical standards, the Drug ECDC, with the deployment of the National Drug Administration, organized the Guidelines for Clinical Trials of Lituxim-Statin-Injection Biosimilars (see annex).
    In accordance with the requirements of the Notice of the General Division of the State Drug Administration on the Procedures for the Issuance of Technical Guidelines for the Issuance of PharmaceuticalS (No. 9 of THE Drug Administration(ICB) 2020), the State Drug Administration shall, upon examination and approval, be issued and shall come into effect from the date of publication.
    hereby hereby notice.
    Guidelines for clinical trials of litoxima-injectable biosimilars at the National Drug Administration's Drug Review Center on July 20, 2020. pdf.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.